FDA Inspection 994527 — Shiratori Pharmaceutical Co. Ltd.

Shiratori Pharmaceutical Co. Ltd. — FEI 3002808233

The FDA completed an inspection of Shiratori Pharmaceutical Co. Ltd. on Nov 4, 2016 in Chiba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 4, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chiba (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.